Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 1
2007 1
2008 1
2009 4
2010 3
2011 5
2012 1
2015 2
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Melanoma: from darkness to promise.
Gasent Blesa JM, Grande Pulido E, Alberola Candel V, Provencio Pulla M. Gasent Blesa JM, et al. Among authors: grande pulido e. Am J Clin Oncol. 2011 Apr;34(2):179-87. doi: 10.1097/COC.0b013e3181d6b427. Am J Clin Oncol. 2011. PMID: 20498590 Review.
Biology of BMP signalling and cancer.
Blanco Calvo M, Bolós Fernández V, Medina Villaamil V, Aparicio Gallego G, Díaz Prado S, Grande Pulido E. Blanco Calvo M, et al. Among authors: grande pulido e. Clin Transl Oncol. 2009 Mar;11(3):126-37. doi: 10.1007/s12094-009-0328-8. Clin Transl Oncol. 2009. PMID: 19293049 Free article. Review.
Cytokine and endocrine signaling in prostate cancer.
Puente Vazquez J, Grande Pulido E, Anton Aparicio LM. Puente Vazquez J, et al. Among authors: grande pulido e. Med Oncol. 2012 Sep;29(3):1956-63. doi: 10.1007/s12032-011-0036-4. Epub 2011 Aug 20. Med Oncol. 2012. PMID: 21858553 Review.
New insights into molecular mechanisms of sunitinib-associated side effects.
Aparicio-Gallego G, Blanco M, Figueroa A, García-Campelo R, Valladares-Ayerbes M, Grande-Pulido E, Antón-Aparicio L. Aparicio-Gallego G, et al. Among authors: grande pulido e. Mol Cancer Ther. 2011 Dec;10(12):2215-23. doi: 10.1158/1535-7163.MCT-10-1124. Mol Cancer Ther. 2011. PMID: 22161785 Review.
Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Gómez Sáez JM, Jiménez-Fonseca P, Santamaría Sandi J, Capdevila Castillón J, Navarro González E, Zafón Llopis C, Ramón Y Cajal Asensio T, Riesco Eizaguirre G, Grande Pulido E, Galofré Ferrater JC. Gómez Sáez JM, et al. Among authors: grande pulido e. Endocrinol Nutr. 2015 Mar;62(3):e15-22. doi: 10.1016/j.endonu.2014.11.006. Epub 2015 Jan 9. Endocrinol Nutr. 2015. PMID: 25583658
Cancer and immune response: old and new evidence for future challenges.
de la Cruz-Merino L, Grande-Pulido E, Albero-Tamarit A, Codes-Manuel de Villena ME. de la Cruz-Merino L, et al. Among authors: grande pulido e. Oncologist. 2008 Dec;13(12):1246-54. doi: 10.1634/theoncologist.2008-0166. Epub 2008 Dec 4. Oncologist. 2008. PMID: 19056856 Free article. Review.
22 results